Xenetic Biosciences XBIO
$ 4.24
-0.93%
Quarterly report 2024-Q3
added 11-12-2024
Xenetic Biosciences Balance Sheet 2011-2024 | XBIO
Annual Balance Sheet Xenetic Biosciences
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
- | - | - | -11.5 M | -10.4 M | -572 K | -5.53 M | -4.05 M | 263 K | -2.11 M | 160 K | 181 K | 203 K |
Long Term Debt |
- | - | - | - | - | - | - | - | - | - | 213 K | 213 K | 213 K |
Long Term Debt Current |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | 27 K | 2.92 M | 2.92 M | 2.92 M | 2.94 M | 2.96 M | 3.14 M | 213 K | 213 K | 213 K |
Total Current Liabilities |
810 K | 1.07 M | 1.42 M | 937 K | 1.42 M | 1.6 M | 1.94 M | 1.87 M | 7.34 M | 2.7 M | 3.59 M | 1.4 M | - |
Total Liabilities |
810 K | 1.07 M | 1.42 M | 964 K | 4.33 M | 4.52 M | 4.86 M | 4.8 M | 10.3 M | 5.84 M | 669 K | 417 K | 221 K |
Deferred Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
-193 M | -189 M | -183 M | -177 M | -166 M | -153 M | -146 M | -142 M | -88.1 M | -75.6 M | -317 K | -138 K | -8.24 K |
Total Assets |
10.6 M | 14.7 M | 19.8 M | 13.2 M | 21.5 M | 14.4 M | 19.2 M | 21 M | 16.9 M | 16.3 M | 487 K | 324 K | 222 K |
Cash and Cash Equivalents |
8.98 M | 13.1 M | 18.2 M | 11.5 M | 10.4 M | 572 K | 5.53 M | 4.05 M | 132 K | 2.51 M | 4.84 M | 11.1 M | 17.1 M |
Book Value |
9.8 M | 13.6 M | 18.4 M | 12.2 M | 17.2 M | 9.91 M | 14.3 M | 16.2 M | 6.61 M | 10.5 M | -182 K | -92.9 K | 1.76 K |
Total Shareholders Equity |
9.8 M | 13.6 M | 18.4 M | 12.2 M | 17.2 M | 9.91 M | 14.3 M | 16.2 M | 6.61 M | 10.5 M | 12.6 M | 20.8 M | 14.8 M |
All numbers in USD currency
Quarterly Balance Sheet Xenetic Biosciences
2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
- | - | - | - | - | - | - | - | - | - | - | - | - | 7.96 K | 17.6 K | 27 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 213 K | - | - | - | - | - | - | - | - | - | - | - | 213 K | 213 K | 213 K | 213 K | 213 K | 213 K | 213 K | - | 213 K | 213 K | - |
Total Non Current Liabilities |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
1.01 M | 1.59 M | 716 K | 810 K | 1.07 M | 871 K | 856 K | 1.07 M | 1.05 M | 1.28 M | 1.06 M | 1.42 M | 1.12 M | 966 K | 816 K | 964 K | 964 K | 964 K | 964 K | 4.33 M | 4.33 M | 4.33 M | 4.33 M | 4.52 M | 4.52 M | 4.52 M | 4.52 M | 4.86 M | 4.86 M | 4.86 M | 4.86 M | 4.8 M | 4.8 M | 4.8 M | 4.8 M | 10.3 M | 10.3 M | 10.3 M | 10.3 M | 5.84 M | 5.84 M | 5.84 M | 5.84 M | 6.85 M | 6.85 M | 6.85 M | 6.85 M | 4.59 M | 417 K | 417 K | 459 K | - | 221 K | - | - |
Deferred Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
-196 M | -196 M | -194 M | -193 M | -192 M | -191 M | -190 M | -189 M | -188 M | -187 M | -184 M | -183 M | -181 M | -179 M | -178 M | -177 M | -177 M | -177 M | -177 M | -166 M | -166 M | -166 M | -166 M | -153 M | -153 M | -153 M | -153 M | -146 M | -146 M | -146 M | -146 M | -142 M | -142 M | -142 M | -142 M | -88.1 M | -88.1 M | -88.1 M | -88.1 M | -75.6 M | -75.6 M | -75.6 M | -75.6 M | -58.3 M | -58.3 M | -58.3 M | -58.3 M | -49.7 M | -228 K | - | - | - | - | - | - |
Total Assets |
8.05 M | 9.03 M | 9.39 M | 10.6 M | 12 M | 12.7 M | 13.7 M | 14.7 M | 15.6 M | 16.5 M | 18 M | 19.8 M | 21.3 M | 10.9 M | 11.8 M | 13.2 M | 13.2 M | 13.2 M | 13.2 M | 21.5 M | 21.5 M | 21.5 M | 21.5 M | 14.4 M | 14.4 M | 14.4 M | 14.4 M | 19.2 M | 19.2 M | 19.2 M | 19.2 M | 21 M | 21 M | 21 M | 21 M | 16.9 M | 16.9 M | 16.9 M | 16.9 M | 16.3 M | 16.3 M | 16.3 M | 16.3 M | 19.5 M | 19.5 M | 19.5 M | 19.5 M | 25.4 M | 324 K | 324 K | 352 K | - | 222 K | 222 K | - |
Cash and Cash Equivalents |
6.84 M | 7.3 M | 7.82 M | 8.98 M | 9.78 M | 10.7 M | 12 M | 13.1 M | 13.8 M | 14.9 M | 16.2 M | 18.2 M | 19.7 M | 9.28 M | 10 M | 11.5 M | 11.5 M | 11.5 M | 11.5 M | 10.4 M | 10.4 M | 10.4 M | 10.4 M | 572 K | 572 K | 572 K | 572 K | 5.53 M | 5.53 M | 5.53 M | 5.53 M | 4.05 M | 4.05 M | 4.05 M | 4.05 M | 132 K | 132 K | 132 K | 132 K | 2.51 M | 2.51 M | 2.51 M | 2.51 M | 4.84 M | 4.84 M | 4.84 M | 4.84 M | 11.1 M | 32 K | 32 K | 32 K | 17.1 M | 10 K | 10 K | - |
Book Value |
7.04 M | 7.45 M | 8.68 M | 9.8 M | 10.9 M | 11.9 M | 12.9 M | 13.6 M | 14.5 M | 15.2 M | 16.9 M | 18.4 M | 20.2 M | 9.95 M | 10.9 M | 12.2 M | 12.2 M | 12.2 M | 12.2 M | 17.2 M | 17.2 M | 17.2 M | 17.2 M | 9.91 M | 9.91 M | 9.91 M | 9.91 M | 14.3 M | 14.3 M | 14.3 M | 14.3 M | 16.2 M | 16.2 M | 16.2 M | 16.2 M | 6.61 M | 6.61 M | 6.61 M | 6.61 M | 10.5 M | 10.5 M | 10.5 M | 10.5 M | 12.6 M | 12.6 M | 12.6 M | 12.6 M | 20.8 M | -92.9 K | -92.9 K | -107 K | - | 1.76 K | 222 K | - |
Total Shareholders Equity |
7.04 M | 7.45 M | 8.68 M | 9.8 M | 10.9 M | 11.9 M | 12.9 M | 13.6 M | 14.5 M | 15.2 M | 16.9 M | 18.4 M | 20.2 M | 9.95 M | 10.9 M | 12.2 M | 12.2 M | 12.2 M | 12.2 M | 17.2 M | 17.2 M | 17.2 M | 17.2 M | 9.91 M | 9.91 M | 9.91 M | 9.91 M | 14.3 M | 14.3 M | 14.3 M | 14.3 M | 16.2 M | 16.2 M | 16.2 M | 16.2 M | 6.61 M | 6.61 M | 6.61 M | 6.61 M | 10.5 M | 10.5 M | 10.5 M | 10.5 M | 12.6 M | 12.6 M | 12.6 M | 12.6 M | 20.8 M | -92.9 K | -92.9 K | -107 K | 14.8 M | -92.9 K | 1.76 K | - |
All numbers in USD currency